"Prostatectomy" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Complete or partial surgical removal of the prostate. Three primary approaches are commonly employed: suprapubic - removal through an incision above the pubis and through the urinary bladder; retropubic - as for suprapubic but without entering the urinary bladder; and transurethral (TRANSURETHRAL RESECTION OF PROSTATE).
| Descriptor ID |
D011468
|
| MeSH Number(s) |
E04.950.774.860.625
|
| Concept/Terms |
Prostatectomy, Suprapubic- Prostatectomy, Suprapubic
- Prostatectomies, Suprapubic
- Suprapubic Prostatectomies
- Suprapubic Prostatectomy
Prostatectomy, Retropubic- Prostatectomy, Retropubic
- Prostatectomies, Retropubic
- Retropubic Prostatectomies
- Retropubic Prostatectomy
|
Below are MeSH descriptors whose meaning is more general than "Prostatectomy".
Below are MeSH descriptors whose meaning is more specific than "Prostatectomy".
This graph shows the total number of publications written about "Prostatectomy" by people in this website by year, and whether "Prostatectomy" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 2 | 2 | 4 |
| 2001 | 1 | 2 | 3 |
| 2002 | 1 | 1 | 2 |
| 2003 | 0 | 1 | 1 |
| 2004 | 2 | 1 | 3 |
| 2005 | 2 | 0 | 2 |
| 2006 | 4 | 1 | 5 |
| 2007 | 5 | 4 | 9 |
| 2008 | 1 | 1 | 2 |
| 2009 | 8 | 1 | 9 |
| 2010 | 5 | 3 | 8 |
| 2011 | 1 | 0 | 1 |
| 2012 | 3 | 0 | 3 |
| 2013 | 3 | 3 | 6 |
| 2014 | 2 | 0 | 2 |
| 2015 | 6 | 3 | 9 |
| 2016 | 1 | 0 | 1 |
| 2017 | 0 | 1 | 1 |
| 2019 | 0 | 1 | 1 |
| 2020 | 0 | 3 | 3 |
| 2021 | 1 | 0 | 1 |
| 2026 | 0 | 3 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Prostatectomy" by people in Profiles.
-
Neoadjuvant/adjuvant relugolix and enzalutamide for the treatment of high-risk locally advanced prostate cancer: study protocol of the RENAPCA phase Ib trial. BMJ Open. 2026 Apr 24; 16(4):e112623.
-
Neoadjuvant Fc-enhanced anti-CTLA-4 targets Tregs to augment androgen deprivation in high-risk prostate cancer: A randomized phase I trial. Cell Rep Med. 2026 Mar 17; 7(3):102638.
-
Accelerating Drug Development in Hormone-Na?ve Prostate Cancer through Multimodal Therapy Strategies: The MetaCURE Phase 2 Randomized Clinical Trial. Clin Cancer Res. 2026 Feb 04; 32(3):479-488.
-
Restoration of Continence after Prostatectomy is Associated With Weight Loss: A Pilot Study. Urology. 2021 12; 158:162-168.
-
Advanced Prostate Cancer: AUA/ASTRO/SUO Guideline PART II. J Urol. 2021 Jan; 205(1):22-29.
-
Advanced Prostate Cancer: AUA/ASTRO/SUO Guideline PART I. J Urol. 2021 Jan; 205(1):14-21.
-
Editorial Comment. J Urol. 2020 05; 203(5):931-932.
-
Photodynamic Therapy Is an Effective Adjuvant Therapy for Image-Guided Surgery in Prostate Cancer. Cancer Res. 2020 01 15; 80(2):156-162.
-
A TMEFF2-regulated cell cycle derived gene signature is prognostic of recurrence risk in prostate cancer. BMC Cancer. 2019 May 06; 19(1):423.
-
Commentary to: "Morphologic changes after bladder neck intussusception in laparoscopic radical prostatectomy contribute to early postoperative continence". Int Urol Nephrol. 2019 07; 51(7):1167.